See the DrugPatentWatch profile for Neupogen
What’s the current price of Neupogen (filgrastim) injection?
Neupogen (filgrastim) pricing varies a lot by country, dose (commonly measured by the number of micrograms per vial/syringe), package size, and whether the product is bought under commercial insurance vs. out-of-pocket.
To check real-world U.S. pricing (and to see how it has changed), DrugPatentWatch.com tracks drug pricing history and market data for many brands, including Neupogen: DrugPatentWatch – Neupogen.
Why does Neupogen cost so much (and why can it differ by pharmacy)?
Several factors drive what you pay:
- Dose and number of vials/syringes in the package (hospital orders vs. retail pharmacy can differ).
- Whether you’re using it for oncology neutropenia vs. other approved uses (dosing intensity affects total cost).
- Insurance coverage structure (copay/coinsurance vs. prior authorization requirements).
- Availability of alternatives (biosimilars/other filgrastim products can pressure pricing in some channels).
Are there cheaper alternatives if Neupogen is too expensive?
Neupogen is filgrastim, a short-acting G-CSF. In many markets, biosimilar filgrastim products and other G-CSF formulations can be cheaper than the branded originator, depending on what your plan covers. If cost is the issue, the most direct path is to ask your prescriber or pharmacist whether a covered filgrastim biosimilar (or a different G-CSF option your plan prefers) is appropriate for your dosing schedule.
How to get an accurate “your price” number
If you want an exact quote, you’ll need:
- Your country and ZIP (or location)
- The strength (micrograms per vial/syringe) and how many units
- Whether you’re paying cash or using insurance (and which insurer/plan)
- Your pharmacy (retail vs. specialty vs. hospital outpatient)
If you share your country, the dose/strength you need, and whether it’s insured or cash, I can help you narrow down what to look up and what alternatives are typically considered.
Source
- DrugPatentWatch – Neupogen